Sample memo

What a covenant test memo looks like.

A complete quarterly test memo for a fictional borrower, built on the covenant terms of a real public credit agreement. Download the PDF and the live-formula workbook below.

Total Net LeveragePass, watch
Borrower cert.2.43x
Our calculation2.60x
Maximum2.75x
EBITDA cushion5.4%
Fixed Charge CoveragePass, watch
Borrower cert.3.01x
Our calculation1.36x
Minimum1.20x
EBITDA cushion5.1%
Covenant Test Memo: Marrowfen Components LLC (fictional)
Facility: $25.0M term loan and $10.0M revolver, closed in Q2 2026 · Test period: four quarters ended Sept 30, 2026
Documents: [A] Credit Agreement (public) · [B] Compliance Certificate, Q3 2026 · [C] Q3 2026 financial statements · [D] Add-back schedule ([B]–[D] fictional)
Reviewed and signed by: a Trueline Covenant credit reviewer, [date of review]

1Summary

TestRequirementBorrower cert.Our calculationEBITDA cushionStatus
Total Net Leverage≤ 2.75x2.43x2.60x5.4%Pass, watch difference flagged
Fixed Charge Coverage≥ 1.20x3.01x1.36x5.1%Pass, watch difference flagged

EBITDA cushion = how far EBITDA could fall before a breach, all else equal. This book's watch threshold is 10%.

Both covenants pass on our numbers, but both are much tighter than the certificate shows, for three reasons.

2EBITDA

Line ($M)BorrowerOursSource
Net Income1.401.40[C] p. 3; clause (a)
+ Depreciation and amortization3.103.10[C] p. 5; clause (b)(i)
+ Interest expense2.102.10[C] p. 3; clause (b)(ii)
+ Income taxes0.550.55[C] p. 3; clause (b)(iii)
+ Non-cash equity compensation1.951.95[D] line 2; clause (b)(viii), Annex E p. 2
− Gain on sale of equipment0.00(0.30)[C] p. 3; clause (c)(ii), Annex E p. 3
EBITDA before capped add-backs9.108.80
+ Capped add-backs claimed (closing costs, integration fees, severance)2.202.20[D] lines 4–6; clauses (b)(vi), (b)(vii), (b)(xiii)
Cap: 20.0% of EBITDA before these add-backsnone applied1.76(b)(xiii) proviso, Annex E pp. 2–3
Capped add-backs allowed2.201.760.44 disallowed
EBITDA11.3010.56

Finding 1: add-backs exceed the 20% cap. Three add-back clauses together “shall not exceed 20.0% of EBITDA in any measurement period (before giving effect to such addbacks)” ([A] Annex E pp. 2–3). The certificate takes $2.20M against a $1.76M cap.

Finding 2: an asset-sale gain was not deducted. Clause (c)(ii) requires deducting “any gain arising from the sale of capital assets” ([A] Annex E p. 3). The $0.30M gain is still in the certificate's net income.

3Total Net Leverage Ratio (maximum 2.75x)

Line ($M)BorrowerOursSource
Total Indebtedness (term loan, revolver, capital leases, earn-out)30.47530.475[C] p. 2; “Indebtedness” clause (a), §1.1 p. 18
− Unrestricted cash (netting capped at $7.5M)(3.000)(3.000)[C] p. 2; Annex E p. 4
Net debt27.47527.475Agrees
÷ EBITDA11.3010.56Table above
Total Net Leverage Ratio2.43x2.60xAnnex E §1(b), p. 1

4Fixed Charge Coverage Ratio (minimum 1.20x)

For the first three test dates after closing, every component other than EBITDA is “Annualized” from the start of the facility. At Sept 30, 2026 that means six months of actuals × 2 ([A] Annex E p. 3).

Line ($M)BorrowerOursSource
EBITDA11.3010.56
− Unfinanced capital expenditures(3.90)(5.20) = 2.60 × 2[C] p. 5; Annex E p. 4
− Cash income taxes(0.70)(0.80) = 0.40 × 2[C] p. 5
Numerator6.704.56
Cash interest expense1.602.10 = 1.05 × 2[C] p. 5
+ Scheduled principal0.6251.25 = 0.625 × 2§2.4; [C] p. 5
Fixed Charges2.2253.35
Fixed Charge Coverage Ratio3.01x1.36xAnnex E §1(a), p. 1

Finding 3: fixed charges and capex are on the wrong basis. The certificate uses trailing-twelve-month actuals, which include months before the facility closed and so understate interest and principal on the new debt. On the basis the agreement requires, EBITDA could fall by about $0.54M (5.1%) before a breach.

5Suggested questions for the borrower (draft, for lender use)

  1. Please restate the Q3 certificate applying the 20.0% cap on clauses (b)(vi), (b)(vii) and (b)(xiii), and deducting the $0.30M equipment-sale gain under clause (c)(ii).
  2. Please recompute the Fixed Charge Coverage Ratio using Annualized amounts, as the definition requires for this test date.
  3. The integration fees under clause (b)(vii) need the Agent's approval and must arise within six months of a Permitted Acquisition. Please identify both.
  4. Please confirm how much capex was funded with revolver draws (treated as unfinanced).

6Next test

At Dec 31, 2026 the multiplier changes to 4/3; from Q1 2027 the ratio uses true four-quarter figures. Thresholds stay flat. Both covenants are inside the 10% watch threshold, so all inputs get a second independent check.

Scope: monitoring support that recalculates financial covenants from the documents listed. Not legal advice; it does not interpret the agreement on the lender's behalf.

In a client memo, this is where the reviewer signs and dates.Sample

The workbook keeps every step as a live formula, so you can change an input and watch the tests move. In a client memo, every page reference points to your own documents.

Free covenant test

Want this on one of your own loans?

Send one borrower package and we'll run the same test, free, in 5 business days.

Get a free covenant test Prefer to talk first? Request a call
  • Free on one borrower package
  • Mutual NDA before any documents
  • No obligation